OPTIMIZING THE POSITION OF VEDOLIZUMAB IN TREATMENT SEQUENCES FOR CROHN’S DISEASE: RESULTS FROM A MARKOV MODEL SIMULATION USING REAL-WORLD EVIDENCE

Alessandro Armuzzi  ¹     Andreas Nikolaou  ²     Michal Litkiewicz  ²     Christian Agboton  ³     Song Wang  ⁴     Edouard Louis  ^5    
1 Università Cattolica, Rome, Italy
² Evidera, London, United Kingdom
³ Takeda, Zurich, Switzerland
⁴ Takeda, Cambridge, United States
⁵ University Hospital CHU of Liège, Liège, Belgium

Session
IBD (Posters)

Conference
UEG Week Virtual 2021

Citation
United European Gastroenterology Journal 2021; 9 (Supplement 8)